Our mission is to revolutionize medicine, with the ultimate goal of eliminating human suffering and enabling people to live without the burden of disease. Kriya is a biopharmaceutical company developing gene therapies to address chronic diseases affecting millions of people around the world. With operations in Research Triangle Park, North Carolina, and Palo Alto, California, Kriya has raised over $600 million to advance a broad pipeline of gene therapies in ophthalmology, metabolic disease and neurology. For more information, please visit www.kriyatx.com and follow us on LinkedIn and X (Formerly Twitter).
Company Details
- Employees
- 202
- Founded
- -
- Address
- Morrisville, Nc 27560, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kriyatx.com
- Keywords
- Gene Therapy.
- HQ
- Morrisville, NC
Kriya Therapeutics, Inc. Questions
Kriya Therapeutics, Inc.'s website is http://www.kriyatx.com
Kriya Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/kriyatx
Kriya Therapeutics, Inc. has
202 employees.
View email and phone details for 202
employees at Kriya Therapeutics, Inc..
Kriya Therapeutics, Inc.'s industry is
Biotechnology Research
Kriya Therapeutics, Inc.'s top competitors are
Atsena Therapeutics,
Vertex Pharmaceuticals,
Biogen,
Taysha Gene Therapies,
Sarepta Therapeutics,
Askbio Inc.,
Apogee Therapeutics,
Precision Biosciences, Inc.,
Encoded Therapeutics Inc.,
Beam Therapeutics.
Kriya Therapeutics, Inc.'s categories are Biotechnology Research
Kriya Therapeutics, Inc.'s founding year is 2019
